Lin Shen to HIV Infections
This is a "connection" page, showing publications Lin Shen has written about HIV Infections.
Connection Strength
0.685
-
Achieving a quantitative understanding of antiretroviral drug efficacy. Clin Infect Dis. 2010 Nov 01; 51(9):1105-6; author reply 1106-7.
Score: 0.171
-
Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection. J Allergy Clin Immunol. 2008 Jul; 122(1):22-8.
Score: 0.146
-
Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs. Nat Med. 2008 Jul; 14(7):762-6.
Score: 0.145
-
A quantitative basis for antiretroviral therapy for HIV-1 infection. Nat Med. 2012 Feb 19; 18(3):446-51.
Score: 0.047
-
Unstimulated primary CD4+ T cells from HIV-1-positive elite suppressors are fully susceptible to HIV-1 entry and productive infection. J Virol. 2011 Jan; 85(2):979-86.
Score: 0.043
-
A novel method for determining the inhibitory potential of anti-HIV drugs. Trends Pharmacol Sci. 2009 Dec; 30(12):610-6.
Score: 0.040
-
New approaches for quantitating the inhibition of HIV-1 replication by antiviral drugs in vitro and in vivo. Curr Opin Infect Dis. 2009 Dec; 22(6):574-82.
Score: 0.040
-
The HBV drug entecavir - effects on HIV-1 replication and resistance. N Engl J Med. 2007 Jun 21; 356(25):2614-21.
Score: 0.034
-
Preferential cytolysis of peripheral memory CD4+ T cells by in vitro X4-tropic human immunodeficiency virus type 1 infection before the completion of reverse transcription. J Virol. 2008 Sep; 82(18):9154-63.
Score: 0.009
-
Decay dynamics of HIV-1 depend on the inhibited stages of the viral life cycle. Proc Natl Acad Sci U S A. 2008 Mar 25; 105(12):4832-7.
Score: 0.009